ENLV

Enlivex Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Enlivex Therapeutics Ltd ENLV NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-0.12 -2.23% 5.25 5.17 5.51 5.33 5.37 00:00:06
more quote information »

Recent News

Date Time Source Heading
6/29/202008:01EDGARReport of Foreign Issuer (6-k)
6/18/202008:33EDGARReport of Foreign Issuer (6-k)
6/15/202006:58EDGARReport of Foreign Issuer (6-k)
5/28/202009:26EDGARReport of Foreign Issuer (6-k)
5/19/202008:05EDGARReport of Foreign Issuer (6-k)
5/18/202016:31EDGARReport of Foreign Issuer (6-k)
5/07/202008:02EDGARReport of Foreign Issuer (6-k)
4/30/202016:21EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
4/13/202008:33EDGARReport of Foreign Issuer (6-k)
4/13/202008:25GLOBEEnlivex Selected by the Israel Innovation Authority to..
3/18/202008:27EDGARReport of Foreign Issuer (6-k)
3/18/202008:00GLOBEEnlivex Announces Positive Final Safety and Efficacy Data..
3/09/202008:13GLOBEIsrael Patent Office Grants New Patent Covering Enlivex’s..
3/05/202008:17EDGARReport of Foreign Issuer (6-k)
3/05/202008:15GLOBEEnlivex Therapeutics Closes $16.75 Million Registered Direct..
3/03/202017:15EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/03/202008:53GLOBEEnlivex Therapeutics Confirms Public Statements Made by the..
3/02/202008:00GLOBEEnlivex Therapeutics Announces $16.75 Million Registered..
2/26/202016:16EDGARReport of Foreign Issuer (6-k)
2/26/202013:46GLOBEEnlivex Therapeutics Closes $8.0 Million Registered Direct..
2/26/202008:24EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/24/202013:54GLOBEEnlivex Therapeutics Announces $8.0 Million Registered..
2/24/202006:31EDGARReport of Foreign Issuer (6-k)
2/24/202006:30GLOBEEnlivex Therapeutics Announces Plan for Increased Production..
2/20/202008:38GLOBEData On Enlivex’s Allocetra-OTS Immunotherapy for Peritoneal..
2/14/202006:16EDGARAmended Statement of Ownership (sc 13g/a)
1/31/202016:32EDGARAmended Annual and Transition Report (foreign Private..
1/23/202016:32EDGARAmended Annual and Transition Report (foreign Private..
11/20/201916:47EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/20/201916:14GLOBEEnlivex Therapeutics Ltd. Announces Proposed Offering of..
11/18/201908:30GLOBEEnlivex Therapeutics Completes Recruitment In Phase Ib Trial..
11/14/201907:31EDGARReport of Foreign Issuer (6-k)
11/12/201907:30GLOBEEnlivex Therapeutics To Present At The 10th Annual ..
11/04/201907:31EDGARReport of Foreign Issuer (6-k)
11/04/201907:30GLOBEEnlivex Therapeutics Announces Positive Interim Safety and..
10/24/201908:01EDGARReport of Foreign Issuer (6-k)
10/24/201907:30GLOBEEnlivex Announces Appointment of New Chief Executive Officer
10/10/201907:30GLOBEPreclinical Data Indicating Allocetra-OTS As Potential..
10/08/201907:30GLOBEEuropean Patent Office Grants New Patent Covering Enlivex’s..
10/07/201907:30GLOBEData On Combination Of Allocetra-OTS Immunotherapy and CAR-T..
9/30/201906:10EDGARReport of Foreign Issuer (6-k)
9/23/201907:30GLOBEFirst Data On Combination Of Enlivex’s Allocetra-OTS..
9/09/201916:09EDGARAmended Statement of Ownership (sc 13g/a)
9/09/201908:01EDGARReport of Foreign Issuer (6-k)
9/09/201907:30GLOBENew Patent Covering Enlivex’s AllocetraTM Immunotherapy Was..
9/04/201907:30GLOBEEnlivex Therapeutics To Present At The 21st Annual Global..
8/19/201907:32EDGARReport of Foreign Issuer (6-k)
8/19/201907:30GLOBEEnlivex Therapeutics Announces Positive Outcome From Safety..
See more news about this stock »
Your Recent History
NASDAQ
ENLV
Enlivex Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200808 21:32:52